Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)

Clinical trial NCT03648554 · UNKNOWN

Trial details

NCT number: NCT03648554
Sponsor: Central Hospital, Nancy, France
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 NASH - Nonalcoholic Steatohepatitis

Start date: 2019-09-01
Primary completion: 2023-09-30
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.